Skip to search formSkip to main contentSkip to account menu

LY2784544

Known as: LY 2784544 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In this study, we identified two previously described kinase inhibitors—3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(3-methyl-1H… 
Highly Cited
2014
Highly Cited
2014
We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond… 
Highly Cited
2013
Highly Cited
2013
Owing to the prevalence of the JAK2V617F mutation in myeloproliferative neoplasms (MPNs), its constitutive activity, and ability… 
Review
2013
Review
2013
Background MF, PV, and ET are neoplasms characterized by activation of JAK2 signaling, and the majority of cases are associated… 
Review
2013
Review
2013
Introduction: Dysregulation of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is central to… 
Review
2012
Review
2012
JAK-STAT (Janus associated kinase-signal transducer and activator of transcription) pathway plays a critical role in transduction… 
Review
2012
Review
2012
Purpose of reviewMyeloproliferative neoplasms (MPNs) are diseases that carry the JAK2 (V617F) mutation in about 70% of the… 
2011
2011
Abstract 2814 Background: The majority of primary and secondary MF, PV, and ET neoplasms are characterized by gain-of-function… 
2010
2010
Abstract 4087 Introduction: The JAK2-V617F mutation is the most common molecular abnormality in the BCR/ABL-negative myeloid…